opportun keep buy
good result help re-establish compani track record investor
underscor predict consist compani busi management
continu progress two front especi recent re-inclus
network juli roll-out pln provid
major driver volum growth expect growth earn multipl
continu firm gradual
summari solid top bottom-lin driven organ volum growth
beat slightli top line vs stronger expect
y/i organ volum growth includ headwind exit
capit contract vs off-set y/i declin revenu per
req abl leverag better expect overal volum growth along
save cost effici program slight ebitda beat vs
ep beat management re-affirmed aspect guidanc
meaning opportun remain expand access pln
beyond similar arrang like horizon w/ payor
alreadi seen three quarter solid sequenti y/i organ volum
growth mostli due move in-network w/ jan believ
compani continu see increment organ volum build
gain larger share mix account histor sent
req multipl lab detail apr dgx/lh upgrad note expect
major benefit inclus pln begin primarili
market optumcar physician larg popul
member incentiv physician beneficiari behavior
quickli effect long-term benefit beyond accru
signific market among commerci member depend employ
adopt pln network addit note management activ
discuss number payor regard similar value-bas payment
pln-like arrang nation health plan would surpris see
increment narrow network announc
return earn stabil rel safeti neg polit rhetor
even take account multipl expans seen sinc stock bottom
dec ntm price-to-earnings believ return earn stabil predict
ep upsid last quarter coupl acceler earn growth solid
dividend yield rel safeti much neg polit rhetor
legisl action aim healthcar sector translat premium valuat
multipl expans current level thu rais pt
deriv appli price-to-earnings ep estim
began report adj ep exclud amort expens
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
began report adj ep exclud amort expens
top-lin growth primarili driven acquisit
w/ increment revenu uplift relat
cost effici program success achiev
save goal oper expens
abl realiz plan
network in-network rate differenti
pressur combin impact
expect revenu uplift relat recent in-
network inclus w/ health plan larger
invigor program abl take
oper expens abl exceed
network in-network rate differenti
pressur result impact less
ep valuat premium
top-lin growth acquisit
lower
anticip revenu uplift relat recent in-
network inclus w/ health plan realiz
invigor program abl take
oper expens plan acquisit synergi
lower anticip
network in-network rate differenti
pressur result impact
ep valuat price-to-earnings low
end histor rang price target
buy rate given belief
announc prefer lab network posit
catalyst stock inclus like bolster
organ growth begin
believ dgx lt growth rate target
 revenu earn attain
compani robust enabl pursu
accret acquisit organ volum
pleas see import disclosur inform page report
pleas see import disclosur inform page report
 dollar thousand unless otherwis indic year end growth q/q- -- -- -- growth gross intang oper expens incom method earn pre-tax incom continu incom averag dilut dilut growth dilut ep growth growth size statementnet gross intang oper expens incom method earn pre-tax incom continu incom dollar thousand unless otherwis indic -fiscal year end cash receiv current total current asset total portion long-term portion oper payabl accru total current portion oper total liab share exhibit statement
pleas see import disclosur inform page report
 dollar thousand unless otherwis indic -fiscal year end doubt compens non-cash work flow oper invest flow invest issuanc issuanc financ flow financ increas decreas ratiosbad debt compens expens expenditur a- -- -- -- -- -- -- -- -- -- -- -acquisit pp -- -- -- -- -- -- -- -- -- -- -free equiti research
one two domin player laboratori test servic market provid routin esoter
diagnost test nation network primari laboratori patient servic center smaller rapid respons laboratori
compani offer array clinic laboratori test includ esoter gene-bas medic test
pt deriv appli price-to-earnings ep estim risk market share gain independ region lab
less expect increment pama cut out-year
brian tanquilut certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
bryan ross cfa certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
jason plagman certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
case jefferi employe analyst respons coverag financi instrument discuss
report receiv compens base part overal perform firm includ invest bank incom seek
updat research appropri variou regul may prevent us asid certain industri report publish
period basi larg major report publish irregular interv appropri analyst judgement
articl articl
explan jefferi rate
buy describ secur expect provid total return price appreci plu yield within period
hold describ secur expect provid total return price appreci plu yield plu minu within
under-perform describ secur expect provid total return price appreci plu yield minu less within
expect total return price appreci plu yield buy rate secur averag secur price consist
within period compani typic volatil overal stock market hold rate
secur averag secur price consist expect total return price appreci plu yield plu minu
within period under-perform rate secur averag secur price consist expect
total return price appreci plu yield minu less within period
nr invest rate price target temporarili suspend suspens complianc applic
cs coverag suspend jefferi suspend coverag compani
nc cover jefferi cover compani
restrict describ issuer conjunct jefferi engag certain transact compani polici applic
secur regul prohibit certain type commun includ invest recommend
pleas see import disclosur inform page report
